These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30222931)

  • 1. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells.
    Parmar MB; K C RB; Löbenberg R; Uludağ H
    Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
    Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
    Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
    Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
    J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.
    Santadkha T; Skolpap W; K C R; Ansari A; Kucharski C; Atz Dick T; Uludağ H
    Invest New Drugs; 2022 Oct; 40(5):962-976. PubMed ID: 35834040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes.
    Lu S; Morris VB; Labhasetwar V
    Mol Pharm; 2015 Feb; 12(2):621-9. PubMed ID: 25591125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spermine-Based Poly(β-amino ester)s for siRNA Delivery against Mutated KRAS in Lung Cancer.
    Jin Y; Adams F; Isert L; Baldassi D; Merkel OM
    Mol Pharm; 2023 Sep; 20(9):4505-4516. PubMed ID: 37578116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Nanomedicines for Breast Cancer Therapy.
    Abbasi Dezfouli S; Rajendran AP; Claerhout J; Uludag H
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies.
    Aliabadi HM; Bahadur K C R; Bousoik E; Hall R; Barbarino A; Thapa B; Coyle M; Mahdipoor P; Uludağ H
    Acta Biomater; 2020 Jan; 102():351-366. PubMed ID: 31760224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.
    Rafael D; Gener P; Andrade F; Seras-Franzoso J; Montero S; Fernández Y; Hidalgo M; Arango D; Sayós J; Florindo HF; Abasolo I; Schwartz S; Videira M
    Drug Deliv; 2018 Nov; 25(1):961-972. PubMed ID: 29667444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
    Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
    Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linoleic-acid-substituted polyethylenimine to silence heat shock protein 90B1 (HSP90B1) to inhibit migration of breast cancer cells.
    Meenakshi Sundaram DN; Kc RB; Uludağ H
    J Gene Med; 2022 Jun; 24(6):e3419. PubMed ID: 35373897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI.
    Liu S; Huang W; Jin MJ; Fan B; Xia GM; Gao ZG
    Eur J Pharm Sci; 2016 Jan; 82():171-82. PubMed ID: 26554721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.
    Mattheolabakis G; Ling D; Ahmad G; Amiji M
    Pharm Res; 2016 Dec; 33(12):2943-2953. PubMed ID: 27528390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
    Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
    J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of Branched Poly(ethylene imine) with d-Fructose for Selective Delivery of siRNA into Human Breast Cancer Cells.
    Peschel JM; Reichel LS; Hoffmann T; Enzensperger C; Schubert US; Traeger A; Gottschaldt M
    Macromol Biosci; 2023 Dec; 23(12):e2300135. PubMed ID: 37565461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.
    Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ofek P; Tiram G; Kalinski H; Avkin-Nachum S; Feiner Gracia N; Albertazzi L; Satchi-Fainaro R
    Nanomedicine; 2018 Feb; 14(2):303-315. PubMed ID: 29127036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy.
    Hao F; Dong S; Yang C; Li Z; Cheng Z; Zhong L; Teng L; Meng Q; Lu J; Wu F; Xie J; Teng L; Lee RJ
    Anticancer Res; 2019 Mar; 39(3):1169-1178. PubMed ID: 30842146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells.
    Meenakshi Sundaram DN; Kucharski C; Parmar MB; Kc RB; Uludağ H
    Macromol Biosci; 2017 Jun; 17(6):. PubMed ID: 28160423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.